Dr. John Rundback, MD
Claim this profileHoly Name Medical Center
Affiliated Hospitals
Holy Name Medical Center
NJ Endovascular And Amputation Prevention, LLP
Clinical Trials John Rundback, MD is currently running
Esprit BTK System
for Critical Limb Ischemia
The Esprit BTK PAS is a prospective, single-arm, multi-center observational study to assess the continued safety and effectiveness of the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System under commercial use, in patients with diseased infrapopliteal lesions causing CLTI (Chronic Limb-Threatening Ischemia) in a real-world setting. The clinical investigation will be conducted at up to 50 sites in the United States (US) and additional sites may be added outside of the US (OUS). Approximately 200 patients with a minimum of 50% of patients in the US will be registered in the clinical investigation.
Recruiting
1 award
N/A
4 criteria
ClotTriever vs Anticoagulation
for Deep Vein Thrombosis
This trial compares the effectiveness of the ClotTriever System, which removes blood clots from veins, to standard blood-thinning medication in patients with symptomatic blood clots in one leg. The ClotTriever System, developed by Inari Medical, is a mechanical device used to treat deep vein thrombosis (DVT) by removing blood clots from veins.
Recruiting
1 award
N/A
5 criteria
More about John Rundback, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments John Rundback, MD has experience with
- Misago® RX Self-expanding Peripheral Stent
- Percutaneous Transluminal Angioplasty (PTA) Device
- Esprit BTK Device
- Bare Temporary Spur Stent System
- BioMimics 3D Vascular Stent System
- Duo Venous Stent System
Breakdown of trials John Rundback, MD has run
Critical Limb Ischemia
Peripheral Artery Disease
Peripheral Arterial Disease
Central Venous Access Device Thrombosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Rundback, MD specialize in?
John Rundback, MD focuses on Critical Limb Ischemia and Peripheral Artery Disease. In particular, much of their work with Critical Limb Ischemia has involved treating patients, or patients who are undergoing treatment.
Is John Rundback, MD currently recruiting for clinical trials?
Yes, John Rundback, MD is currently recruiting for 3 clinical trials in Teaneck New Jersey. If you're interested in participating, you should apply.
Are there any treatments that John Rundback, MD has studied deeply?
Yes, John Rundback, MD has studied treatments such as Misago® RX Self-expanding Peripheral Stent, Percutaneous Transluminal Angioplasty (PTA) Device, Esprit BTK Device.
What is the best way to schedule an appointment with John Rundback, MD?
Apply for one of the trials that John Rundback, MD is conducting.
What is the office address of John Rundback, MD?
The office of John Rundback, MD is located at: Holy Name Medical Center, Teaneck, New Jersey 07666 United States. This is the address for their practice at the Holy Name Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.